Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-14 Purchase |
2023-02-16 5:04 pm |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
1,250,000 | $16 | $20,000,000 | 1,311,247 (Indirect) |
View |
| 2023-02-14 Purchase |
2023-02-16 4:54 pm |
Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO, Chief Bus. Off. and Secy. |
6,250 | $16 | $100,000 | 350,811 (Direct) |
View |
| 2023-02-14 Purchase |
2023-02-16 4:54 pm |
Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner |
937,500 | $16 | $15,000,000 | 4,519,361 (Indirect) |
View |
| 2023-02-14 Purchase |
2023-02-16 4:54 pm |
Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner |
250,000 | $16 | $4,000,000 | 9,194,579 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-14 Conversion |
2023-02-16 5:04 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
1,928,476 | $0 | 1,311,247 (Indirect) |
View |
| 2023-02-14 Conversion |
2023-02-16 4:54 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner |
7,163,722 | $0 | 4,519,361 (Indirect) |
View |
| 2023-02-14 Conversion |
2023-02-16 4:54 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner |
8,628,186 | $0 | 9,194,579 (Indirect) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:13 pm |
N/A 2023-02-09 |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
44,000 | $0 | 44,000 (Indirect) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:03 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:03 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | DiRocco Derek Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:03 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Takahashi Takeshi Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:02 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Litzka Olivier Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:02 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:02 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Asam Alexander Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:01 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
250,046 | $0 | 250,046 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:01 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO, Chief Bus. Off. and Secy. |
97,518 | $0 | 97,518 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:01 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
104,186 | $0 | 104,186 (Direct) |
View |
Ownership |
2023-02-09 9:04 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | HBM Healthcare Investments (Cayman) Ltd. 10% Owner |
0 | $0 | 2,905,606 (Direct) |
View |
Ownership |
2023-02-09 8:06 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 1,928,476 (Indirect) |
View |
Ownership |
2023-02-09 7:55 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO, Chief Bus. Off. and Secy. |
0 | $0 | 344,561 (Direct) |
View |
Ownership |
2023-02-09 7:53 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner |
0 | $0 | 8,944,579 (Indirect) |
View |
Ownership |
2023-02-09 7:53 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
0 | $0 | 545,557 (Direct) |
View |
Ownership |
2023-02-09 7:52 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
0 | $0 | 1,062,400 (Direct) |
View |
Ownership |
2023-02-09 7:52 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner |
0 | $0 | 3,581,861 (Indirect) |
View |